Skip to Content Skip to Footer
Sheryl Chow, PharmD, FCCP, FAHA, FHFSA, BCPS AQ-Cardiology

Sheryl Chow, PharmD, FCCP, FAHA, FHFSA, BCPS AQ-Cardiology

Associate Professor of Pharmacy Practice and Administration

College of Pharmacy

Phone: 909-469-5379

Join year: 2004

  • Education

    BS Pharmacy, Honors Scholar 1998
    University of Connecticut

    Pharm.D. 2000
    State University of New York at Buffalo

    Dr. Sheryl Chow received her B.S. in Pharmacy from the University of Connecticut and Pharm.D. from the State University of New York at Buffalo. She completed a Pharmacy Practice Residency at Buffalo General Hospital.

  • Education Experience

    Residency Pharmacy Practice 2000-2001
    Buffalo General Hospital (Kaleida Health Systems)

    Kaleida Health Systems/State University of NY-Buffalo

  • Certification

    2016 Fellow, Heart Failure Society of America

    2012 Fellow, American Heart Association

    2011 Fellow, American College of Clinical Pharmacy

    2008Advanced Qualifications in Cardiology (AQ card)

    2003Board Certified Pharmacotherapy Specialist (BCPS)
    Board of Pharmaceutical Specialties

  • Professional Experience


    2018 Interviewed and quoted in TCTMD Press Release of newly published meta-analysis, “High-Sensitivity Troponin May Help Uncover Heart Failure Risk”

    10/9/17 Interviewed and quoted in Medscape about Prescribing Pitfalls in Heart Failure With Multiple Comorbidities.

    4/19/17 American Heart Assocation Press Release and one-to-one interview by AHA Reporter on publication of New Scientific Statement: New guidance on heart failure tests can improve care.

    3/28/17 Multidisciplinary Perspectives on Appropriate Initiation of Evidence-Based Therapies in the Management of Congestive Heart failure: Filming and video 12 part series. MD Magazine.

    Also presented on Pharmacy Times - Website:

    11/11 Western University News Interview: Chows become first parent-child to be honored as Fellow's in ACCP.

    10/17/11 ACCP Daily Newspaper Interview: The role of genetics in cardiovascular pharmacotherapy up for debate. This newspaper interview with reporter focuses on the highlights of the joint ACCP programming with the American Heart Association.

    3/2/10 Public Broadcast Systems (PBS): American Health Journal Television (30 minute syndicated show): Segment: Colleges of Pharmacy and Veterinary Medicine. Interviewed and discussed topics including interprofessional education, impact of pharmacy students, and student curriculum. Aired on KOCE (PBS) at 8:30 a.m. Tuesday, March 2.

    6/6/08 KABC Channel 7 News/ Healthy Living (Consultant Interview): Lowering Costs on Prescription Drugs The segment with health reporter, Denise Dador, focuses on mail order prescriptions and reducing costs associated with cardiovascular medications.

  • Work Site

    Research site:

    Division of Cardiology
    Department of Medicine
    University of California, Irvine
    UCI Medical Center
    Orange, CA 92868

    Rotation site:

    Riverside Community Hospital
    4445 Magnolia Ave.
    Riverside, CA 92501

    The medicine/cardiology clerkship is designed to provide clinical experiences in a teaching hospital (HCA and UCR affiliated) for the management of patients with acute heart failure, acute coronary syndromes, and other urgent cardiovascular diseases. Students will be involved in direct patient care activities in the emergency department, telemetry, and intensive care unit, as members of the cardiology teaching service. Current rotations available: Medicine/cardiology, cardiovascular research, and advanced elective.

  • Teaching Experience

    Before joining the Faculty at Western University in 2004, Dr. Chow worked as a Clinical Pharmacy Coordinator for both the Internal Medicine Teaching Service and Cardiology, in addition to her adjunct faculty positions in both the Schools of Pharmacy and Medicine at SUNY-Buffalo. Her didactics, clinical practice, and research interests at Western University are focused in acute care cardiology with an emphasis on heart failure.

  • Publications

    Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations. Khan SS., Matsushita K, Sang Y, Ballew SH, Grams ME, Surapanemi A, Blaha MJ, Carson AP, Chang AR, Ciemins E, Go AS, Gutierrez OM, Hwang SJ, Jassal SK, Kovesdy CP, Lloyd-Jones DM, Shlipak MG, Palaniappan LP, Sperling L, Virani SS, Tuttle Km, Neeland IJ, Chow SL, Ragaswami J, Pencina MJ, Ndumele CE, Coresh J., and for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Nov 10, 2023.Circulation. 2023;0.

    Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart AssociationKhan SS, Coresh J, Pencina MJ, Ndumele CE, Ragaswami J, Chow SL, Palaniappan LP, Sperling LS, Virani SS, Ho JE, Neeland IJ, Tuttle KR, Rajgopal R,, Elkind MS, Lloyd-Jones DM; on behalf of the American Heart Association. Circulation. 2023;XXX:e00–e00. DOI: 10.1161/CIR.0000000000001191.

    Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS Coresh J, Mathew RO, Baker-Smith CM, Camethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekovich CL, Lewis EF, Lo KB, Ozkao B, Palanianppan LP, Patel SS, Pencina MJ, Powel-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal-Singh R, Elkind MS. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory from the American Heart Association. 9 Oct 2023, Circulation, online ahead of print.

    Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekovich CL, Lewis EF, Lo KB, Ozkao B, Palanianppan LP, Patel SS, Pencina MJ, Powel-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal-Singh R, Elkind MS. Rangaswami J. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement from the American Heart Association. Circulation 2023 Oct 9. doi: 10.1161/CIR.0000000000001186.

    Page RL,Chow SL. Polypharmacy and the Clinical Inertia Conundrum for GDMTJACC Heart Fail. 2023 14:S2213-1779(23)00542-5. doi: 10.1016/j.jchf.2023.08.015. Online ahead of print.

    Kittleson M (Chair), Sharm K (Vice-Chair), Brennan D, Cheng X, Chow SL, Colvin M, DeVore A, Dunlay S, Fraser, M, Garonzik-Wang J, Korenblat K, Khazanie P, Pham DT., Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Simultaneous Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement from the American Heart Association. Circulation. 2023;148:622–636.

    Wang J, Chow SL, Chow MSS, Paik A, Louie SG, Dong F, Sathananthan A, White S. Pharmacokinetics comparison of vardenafil as administered by an intranasal spray formulation vs. a 10-mg oral tablet. J Sex Med 2023. 28;20(7):1004-1009.

    Chow SL (Chair), Bozkurt B, Baker WL, Bleske BE, Breathett K, Fonarow GC, Greenberg B, LaClerc J, Morris AA, Reza N, Yancy CW. AHA Scientific Statement: Complementary and Alternative Therapy in Heart Failure Management. Circulation. 2023;147:e4-e30.

    Chow SL (Chair),Sasson C (Vice-Chair), Benjamin IJ, Califf RM, Compton W, Oliva E, Robson C, Sanchez E. AHA Presidential Advisory: Opioid use and its relationship to cardiovascular and brain health. Circulation. Circulation. 2021;144:e218–e232.

    Chow MSS, Chow SL, Kember D. A conceptual basis and key components for pharmacy core curriculum in the age of artificial intelligence. JAASP. 2018;7:15-20.

    Chow SL, Page RL, Depre C. Role of ivabradine and heart rate lowering in chronic heart failure: guidelineupdate. Expert Rev Cardiovasc Ther. 2018 Jun 14. doi: 10.1080/14779072.2018.1489235.

    Xiao Chen,Xiang Gao,Jie Chen, Chow SL, Chow MSS. New direction for clinical pharmacy in China: adopting a “form follows function” approach to improve future healthcare outcomes. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 352-360.

    Maisel AS, Daniels LB, Anand I, McCullough PA, Chow SL. Utility of Natriuretic Peptides to Assess and Manage Angiotensin Receptor Blocker/Neprilysin Inhibitor Combination Products in Patients with Heart Failure. Postgraduate Med. 2018;130(3):299-307.

    Chow SL(Chair), Maisel A (Vice-Chair), Anand I, Bozkurt B, De Boer, R, Greenberg B, Felker M, Januzzi J, Kiernan M, Fonarow G, Liu P, Wang T, Yancy CW, Zile MR. AHA Scientific Statement: The Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement from the American Heart Association. American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. [Epub ahead of print] Circulation. March 26, 2017. Article link. AHA Press release.

    Gandhi PU, Chow SL, Rector TS, Krum H, Gaggin HK, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Carson PE, Januzzi JL Jr, Anand IS. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. J Card Fail. 2017; 23(1):20-28.

    Fajardo F, Heywood JT, Patterson JH, Adams KA, MD, Chow SL. A focus on nesiritide in recent congestive heart failure trials. Expert Rev Cardiovasc Ther. 2015;13(7):743-751.

    Lanfear DE, Abbas R, Padhukasahasram B, Gupta R, Langholz D, Wilson W, Tang W, Williams K, Sabbah H, Chow SL. Genetic factors influencing b-type natriuretic peptide mediated production of cyclic guanosine mono phosphate and blood pressure effects in heart failure patients. J Cardiovasc Trans Res. 2015; 8:545-553.

    Huynh K, Van Tassell B, Chow SL. Predicting therapeutic response in patients with heart failure: the story of C-reactive protein. Expert Rev Cardiovasc Ther. 2015 Feb;13(2):153-61. doi: 10.1586/14779072.2015.1000307. Epub 2015 Jan 12. PMID: 25578159.

    Lanfear DE, Chow SL, Padhukasahasram B, Li J, Langholz D, Tang W, Williams K, Sabbah HN. Genetic and Non-Genetic Factors Influencing Pharmacokinetics of B-type Natriuretic Peptide. J Card Fail. 2014 Sep;20(9):662-8 PMID 24983826.

    Perugu S, Rehan V, Chow SL, Baylen B. Plasma Biomarkers and Echocardiographic Indices of Left Ventricular Function in Very Low Birth Weight Infants. † J Neonatal Perinatal Med. 2014 Jan 1;7(3):213-22. doi: 10.3233/NPM-14814010. PMID: 25322997.

    LaForest SK, Chow SL, DiDomenico R, Dracup K, Ensor C, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM*. Clinical Pharmacy Services in Heart Failure: An Opinion Paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013 May;19(5):354-69. PMID: 23663818.

    LaForest SK, Chow SL, DiDomenico R, Dracup K, Ensor C, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie BM*.Clinical Pharmacy Services in Heart Failure: An Opinion Paper from the Heart Failure Society of America and College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy. 2013 May;33(5):529-48. PMID: 23649813.

    Wang JSC, Kovanecz I, Vernet D, Nolazco G, Kopchok GE, Chow SL, White RA, Gonzalez-Cadavid NF. Effects of sildenafil and/or muscle derived stem cells on myocardial infarction. † J Transl Med. 2012; 10:1-11. (Impact factor 3.47).

    Chow SL, Ng TM, Litwinski RA, Kangavari S, Weiss, M. Effect of iodixanol and ioxilan on QT interval and renal function in patients with systolic heart failure.† Int J Cardiol 2012; 154(1):17-21. (Impact factor 6.802).

    Talatinian A, Chow SL, Heywood, JT. Mineralocorticoid Receptor Antagonists: an expanding role in heart failure. Pharmacotherapy. 2012; 32(9): 827-837.

    Finks SW, Airee A, Chow SL, MacCauley TE, Moranville MP, Rogers KC Trujillo TC. Key Articles of Dietary Interventions that Influence Cardiovascular Mortality. Pharmacotherapy. 2012; 32(4):e54-87. doi: 10.1002/j.1875-9114.2011.01087.x.

    Chow SL, Singh H, DiDomenico R, Dunn SP, Johnson SG, Marrs J, Vardeny O, Bleske BE. Key Articles Related to Complementary and Alternative Medicine in Cardiovascular Disease: Part II. Pharmacotherapy 2011:31(10)1041.

    Chow SL, O’Barr SA, Peng JT, Chew EE, Pak F, Patel P, Quist R, Patterson JH, Heywood JT. Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: An exploratory study. Circ Heart Fail. 2011;4:450-455.

    Chow SL, O’Barr SA, Peng JT, Chew EE, Pak F, Patel P, Quist R, Patterson JH, Heywood JT. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin vs. nesiritide in patients with acute decompensated heart failure (ABC-HFT study). J Card Fail. 2011 Mar;17(3):181-7.

    Chow SL, Houseman D, Phung T, French W. Transient Acute Decompensated Heart Failure Following Propofol and Fentanyl Administration in a Healthy 19-Year Old Patient. Congestive Heart Failure 2010;16(2):80-81.

    Chow SL, Dorsch M, Dunn S, Jackevicius C, Page RL, Trujillo T, Vardeny O, Wiggins B, Bleske BE. Key Articles Related to Complementary and Alternative Medicine in Cardiovascular Disease: Part I (Vol 30, No 1). Pharmacotherapy 2010;30(1):109.

    Jackevicius CA, Page, RL, Chow S, Dunn SP, Lee CR, Ng TMH, Rodgers JE, Vardeny O, Wiggins BS, Munger MA. High-impact articles related to the management of heart failure: 2008 update. Pharmacotherapy 2009;29:82-120.

    Lead Authors: Barsuk J, Casey DE, Graff LG, Green A, Mace S.; Contributing Authors: Bhargava R, Berkowitz R, Blank L, Chow SL, Hawkins M, Karunaratne H, LeVine T, Moran P, Peacock F, Trupp R, Tsikouris J, Watson P, Yen T, Wellikson L. The Observation Unit: An Observational Overview for the Hospitalist. Society of Hospital Medicine (SHM).

    Chow SL, Peng, J, Okamoto M, Heywood JT. Effect of Nesiritide Infusion Duration on Renal Function in Acutely Decompensated Heart Failure Patients. † Annals of Pharmacotherapy 2007;41(4):556-61.

    Nazer L, Chow SL, Moghissi E. Insulin Infusion Protocols for Critically Ill Patients: A Highlight of Differences and Similarities. Endocr Pract 2007;13:137-146.

    Litwinski RA, Donayre CE, Chow SL, Song TK, Kopchok G, Walot I, White RA. The Role of Aortic Neck Dilation and Elongation in the Etiology of Stent Graft Migration Following Endovascular AAA Repair with a Passive Fixation Device. † Journal of Vascular Surgery 2006;44:1176-81.

    Chow SL, Cheung R. Aspirin Resistance: A growing concern. Formulary 2006; 41:192-201.

    Kwok M, Chow SL, Holt J, Moses Chow. Panic Disorder, A Pharmacologic Armamentarium Formulary 2003; 38:431-438.

    Corbelli J, Janicke D, Chow S, Pruski M ACSETS: Acute Coronary Syndrome Emergency Treatment Strategies. Critical Pathways in Cardiology 2003;2(2):71-87.

    Chow SL, Zammit K, West K, Dannenhoffer MA, Lopez-Candales A. Correlations with Renal Function and Anti-Factor Xa in patients on Low Molecular Weight Heparin. Journal of Clinical Pharmacology 2003;43:586-590.

    Chow SL, Luzier AB, DiTusa L, Snyder BD, Izzo JL. Acid-Suppressive Therapy Use Associated with Antihypertensive Agents. Journal of Clinical Pharmacology. 2001;41:750-756.

    Chow SL, Tomlinson B, Chow M. Pharmacologic management of insomnia: assessing the nonbenzodiazepine hypnotics. Formulary. 2000;35(11):894-903.